Francesco Ferrau
Messina, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 175 publications
Safety and effectiveness of setmelanotide in young patients with severe obesity due to craniopharyngioma: a real world monocentric experience.
Journal: Journal of endocrinological investigation
Published: March 13, 2026
PEPTIDE RECEPTOR RADIONUCLIDE THERAPY (PRRT) AND THE PITUITARY: SAFETY AND EFFICACY.
Journal: Endocrine-related cancer
Published: March 03, 2026
Real-World Effectiveness and Safety of Osilodrostat in Cushing's Syndrome: A Retrospective Phase IV Study.
Journal: The Journal of clinical endocrinology and metabolism
Published: January 01, 2026
Metabolic syndrome in cushing's syndrome patients: Does gender matter?
Journal: Pituitary
Published: December 07, 2025
Gender differences in the glycometabolic and cardiovascular features of acromegaly.
Journal: Pituitary
Published: November 25, 2025
Reply to: Rethinking the global epidemiology of pheochromocytoma: glimpses of a larger reality.
Journal: Journal of endocrinological investigation
Published: October 10, 2025
Vitamin D Supplementation and Testosterone Levels in Breast Cancer Survivors.
Journal: International journal of molecular sciences
Published: September 11, 2025
Germline targeted next-generation sequencing in patients with adrenal incidentalomas.
Journal: Frontiers in endocrinology
Published: August 13, 2025
AIMN, ITANET, SIE joint position paper for the recognition, prevention and management of NET carcinoid syndrome and crises during peptide receptor radionuclide therapy.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 20, 2025
Last Updated: 09/26/2026